Staar ICL Implantable Contact Lens Approvable With Conditions – Panel
This article was originally published in The Gray Sheet
Executive Summary
Staar's Collamer ICL implantable contact lens should be approved for myopia despite concerns over procedure-related endothelial cell loss, FDA's Ophthalmic Devices Panel concluded in an 8-3 vote late on Oct. 3 in Gaithersburg, Maryland
You may also be interested in...
Staar Will Respond To FDA On “Serious, Continuing Violations”
Staar Surgical said it would issue a report to FDA July 15 detailing the firm's plans for resolving a series of quality systems violations
Staar Will Respond To FDA On “Serious, Continuing Violations”
Staar Surgical said it would issue a report to FDA July 15 detailing the firm's plans for resolving a series of quality systems violations
Staar Tackles Compliance Issues; AMO Sets Sights On Overseas Lens Market
Staar Surgical will create a dedicated compliance office as part of an operational restructuring to boost its regulatory standing in the wake of two warning letters issued by FDA since December